Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza
about
The immunology of influenza virus-associated bacterial pneumoniaLimited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia.Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced diseaseCurrent concepts in host-microbe interaction leading to pneumococcal pneumoniaImmunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung Tissue.The Influence of Programmed Cell Death in Myeloid Cells on Host Resilience to Infection with Legionella pneumophila or Streptococcus pyogenes.Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfectionIn vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infectionToll-Like Receptor 2 Recognizes Orientia tsutsugamushi and Increases Susceptibility to Murine Experimental Scrub TyphusInfluenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice.Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection.Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection.Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza.Recognition of Streptococcus pneumoniae by the innate immune system.Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?Treatment with anti-inflammatory drugs in community-acquired pneumonia.Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.Beneficial role of vitamin D3 in the prevention of certain respiratory diseases.The role of influenza in the severity and transmission of respiratory bacterial diseaseInhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.Toll-like receptor-2 exacerbates murine acute viral hepatitis.Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia.Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice.Lung epithelial cells are essential effectors of inducible resistance to pneumonia.TLR7 contributes to the rapid progression but not to the overall fatal outcome of secondary pneumococcal disease following influenza A virus infection.Coinfection: doing the math.Role of human Toll-like receptors in naturally occurring influenza A infections.Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.Busting the Myth of "Static vs. Cidal": A Systemic Literature Review.CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection.IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and Streptococcus pneumoniae Coinfection.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.An Update on Host-Pathogen Interplay and Modulation of Immune Responses during Orientia tsutsugamushi Infection.Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System.Lethal Synergism between Influenza andInduction of the pneumococcal vncRS operon by lactoferrin is essential for pneumonia
P2860
Q28084679-A9A5303A-D7E7-4A71-A826-E537C4DBA198Q31112685-70ABBC29-88F5-472D-9CEA-7DA490F46529Q34149169-7353357B-07FC-4F9A-A03E-6DAC007B23D4Q34540722-0FF84CC3-1686-492A-A4C2-56AAE0CA080AQ34933070-A766CF47-A13F-46AB-8CE1-76F66EEDB90EQ35758711-08F06309-4C59-4298-A7CC-2CC036F36787Q36223568-7C26FB78-5EEE-44AD-99BD-AB2F8B19B279Q36281381-8DB9A584-DEA5-4924-98BD-C3BB49743DCBQ36655336-8DC5E206-2B0B-4EAA-AE6F-CF5587F1E21CQ37424974-4A45BB3D-36CD-4629-A632-9425893D8C8DQ37424992-306CEA9E-7EB6-48CF-807C-27DA925B6BD3Q37607163-64BDE0C6-CD00-487C-99E2-4D561B4CD2B6Q37640922-4F6EC17C-F2DB-4FE0-BFEE-0417317E2083Q37662791-6578EA81-A91F-4F78-B969-520BE0BDEDF5Q37733491-30A8CEE5-8189-4841-82CA-3397E414B3C0Q37972741-18091D7C-2297-4C02-909E-F8C472C7CCD8Q38008471-0770FCD8-8C93-4EEA-A62B-BC0A69203E3DQ38009864-F8E8906D-0B83-424E-B4C3-1FBD49EA6797Q38085248-9730199F-44EB-4275-AF75-5DF700537D02Q38140574-56783CDA-04E7-43BD-AB05-5B4920565A33Q38240678-0D72A322-141C-4A82-8E3B-D34633878BBAQ40201663-F512E57D-5FAB-4F73-B6BB-9948A121BE64Q40641510-A0EE6498-E497-47AE-9F93-D801B434599CQ41657153-3E446EAA-E917-45FE-89AD-DD705B327646Q42239416-BB1C1980-4CB0-40CF-AFF0-404CFA83C659Q42264726-7BC4FC48-43DB-46CF-A2A1-AD85C660C735Q42286383-112BA7F9-F4A8-4638-A6AC-6758AD6A1F66Q44200581-07691DAF-8D4F-4B71-9828-138605790B7CQ44488921-A760B1F6-F98C-46D6-B3B7-5CE45CF4DFA0Q44758803-6978CD5A-92D0-4D69-BFF4-227F74DA6B7AQ47223062-E74615E6-12A5-4788-BFDC-EFE93D11A6B3Q47554827-DD8D3C2F-A902-447D-9CFE-36B7B205E109Q47557097-4AE9172F-1F09-4E69-B0A8-6A5218356D35Q47576940-FB2A69DE-B758-4556-807E-28B4F26A9536Q47701304-B67C0260-8269-423C-81B6-7EECBA6AD9C0Q55514867-F219DA88-5537-4D17-B5E9-66F3351A5509Q56909756-D264BC01-312A-4A87-9EAB-31DE075F35DDQ58699858-82DDA171-D117-4B97-8111-09DFE0AE43D7
P2860
Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
El receptor 2 tipo Toll media ...... secundaria después de la gripe
@es
Le récepteur de type péage 2 i ...... ndaire à la suite de la grippe
@fr
Toll-like receptor 2 mediates ...... pneumonia following influenza
@en
Toll-like receptor 2 mediates ...... pneumonia following influenza.
@ast
type
label
El receptor 2 tipo Toll media ...... secundaria después de la gripe
@es
Le récepteur de type péage 2 i ...... ndaire à la suite de la grippe
@fr
Toll-like receptor 2 mediates ...... pneumonia following influenza
@en
Toll-like receptor 2 mediates ...... pneumonia following influenza.
@ast
prefLabel
El receptor 2 tipo Toll media ...... secundaria después de la gripe
@es
Le récepteur de type péage 2 i ...... ndaire à la suite de la grippe
@fr
Toll-like receptor 2 mediates ...... pneumonia following influenza
@en
Toll-like receptor 2 mediates ...... pneumonia following influenza.
@ast
P2093
P2860
P356
P1476
Toll-like receptor 2 mediates ...... pneumonia following influenza.
@en
P2093
Asa Karlström
Elaine I Tuomanen
Kelli L Boyd
Sarah M Heston
P2860
P304
P356
10.1093/INFDIS/JIR522
P407
P577
2011-09-07T00:00:00Z